The Scientist

» drug development, ecology and immunology

Most Recent

image: Circadian Atlas Chronicles Gene Expression

Circadian Atlas Chronicles Gene Expression

By | October 27, 2014

Researchers have mapped the times of day when mouse genes are transcribed across 12 organs.

1 Comment

image: Ebola Update

Ebola Update

By | October 23, 2014

Vaccine testing could start soon; Spanish nurse declared free of virus; travelers from West Africa restricted to five US airports

3 Comments

image: Virus Decimating Spanish Amphibians

Virus Decimating Spanish Amphibians

By | October 20, 2014

Several toad, newt, and salamander populations are being hit hard by an emerging pathogen in a pristine national park in Spain.

0 Comments

image: Nurse Infected with Ebola in Spain

Nurse Infected with Ebola in Spain

By | October 6, 2014

The case marks the first person to contract the virus outside of West Africa.

0 Comments

image: Contributors

Contributors

By | October 1, 2014

Meet some of the people featured in the October 2014 issue of The Scientist.

1 Comment

image: Epigenetics of Trained Innate Immunity

Epigenetics of Trained Innate Immunity

By | September 25, 2014

Documenting the epigenetic landscape of human innate immune cells reveals pathways essential for training macrophages.

2 Comments

image: FDA OKs siRNA Ebola Drug

FDA OKs siRNA Ebola Drug

By | September 23, 2014

The US Food and Drug Administration gives the green light to deploy an experimental short interfering RNA treatment against Ebola.

0 Comments

image: Bird Diversity Drops From Forests to Farms

Bird Diversity Drops From Forests to Farms

By | September 11, 2014

Farms support less phylogenetically diverse bird populations than forests, but some farms are better than others.

0 Comments

image: Ebola Vaccine Protects Macaques

Ebola Vaccine Protects Macaques

By | September 9, 2014

Human trials are now underway.

0 Comments

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

Popular Now

  1. Symmetrical Eyes Indicate Dyslexia
  2. German Scientists Resign from Elsevier Journals’ Editorial Boards
  3. Germany Sees Drastic Decrease in Insects
  4. GM Mosquitoes Closer to Release in U.S.
RayBiotech